RE:RE:Good results but...Davepark5
Look at the market cap. KTRA is a very small market cap.
For PII biotech with fast track, market is saying 100 millions USD$ is what it is worth.
This is undervalue and all analysts covering this stock is already saying but market sentiment is very negative as the market is pricing in a recession / end of rate hikes.
The general should improve (bullish view), if so SP could shoot higher as specaltion of successful bracelet trial become louder.
A PIII biotech in oncology is worth at least 500 millions...
So ONCY has 33 millions in cash, market is saying that ONCY tech is worth only 66 millions
Wow, this is very cheap valuation. A bargain vs. the potential.